MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

Follow Cold Wallet’s $5.9M presale growth backed by real users and cashback utility, while the Litecoin (LTC) price surge ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

Over the past month, the crypto market has been on fire — and two big names, Litecoin and XRP, have been leading the charge.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

Litecoin ETF approval talk grows as institutional interest rises, fueled by regulatory clarity and LTC’s increasing role in ...

As the crypto market continues to grow in 2025, investors are eagerly searching for the best crypto to buy now. Among the ...

This strategic move, developed in partnership with GSR and with guidance provided by Litecoin Creator and MEI Board member Charlie Lee, marks the beginning of MEI’s broader institutional treasury ...

MEI Pharma (MEIP) just threw Wall Street a curveball by swapping part of its cash pile for Litecoin (LTC) and inviting Litecoin creator Charlie Lee onto its board. That decision comes via a ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ ... MEI represents a significant step toward institutionalizing Litecoin as ...

MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange ...